|
AVBP Arrivent Biopharma Inc 1868279 |
| Income Statement |
|
Net Income
|
2026-03-31
|
$-43,320,000.00 |
| Balance Sheet |
|
Current Assets
|
$348,700,000.00 |
|
Assets
|
$349,295,000.00 |
|
Current Liabilities
|
$24,995,000.00 |
|
Liabilities
|
$25,315,000.00 |
|
Equity
|
$323,980,000.00 |
|
Shares Out
|
45308941.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-41,892,000.00 |
|
Investing Cash Flow
|
$3,582,000.00 |
| Market Analysis |
Market Cap
|
$1,389,172,131.06 |
|
Price
|
$29.73 |
|
BVPS
|
7.15 |
|
PB
|
4.29 |
|
EPS
|
-0.96 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:24 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:20 |
|
| Apr |
May |
Jun |
| 2026-03-05 |
-4.32 |
|
|
2026-05-11 |
-0.96 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-11 |
-0.90 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-10 |
-0.83 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view AVBP documents filed with the SEC.
AVBP Filings
Clear
